Eli Lilly Confirms 'Superior Weight Loss' Of Its Next-Generation Obesity Drug - Investor's Business Daily
Source:Investor's Business Daily
Patients taking retatrutide, lost 16.8% of their body weight over 40 weeks.
Patients taking retatrutide, lost 16.8% of their body weight over 40 weeks.